Analysts Have Conflicting Sentiments on These Healthcare Companies: Electrocore (ECOR), Disc Medicine (IRON) and Allakos (ALLK)
Electrocore's Strong Q1 Performance and Growth Potential Affirm Buy Rating
Earnings Call Summary | ElectroCore(ECOR.US) Q1 2024 Earnings Conference
The following is a summary of the ElectroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript:Financial Performance:ElectroCore reported a sixth consecutive record revenue quarter of $5.4 million for Q1
Electrocore: Strong Financials and Market Penetration Justify Buy Rating With $15 Target
electroCore | 10-Q: Quarterly report
ElectroCore Q1 2024 GAAP EPS $(0.53) Beats $(0.61) Estimate, Sales $5.443M Beat $4.767M Estimate
electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.61) by 13.11 percent. This is a 57.26 percent increase over losses of $(1.24)
Earnings Flash (ECOR) ELECTROCORE Posts Q1 Revenue $5.4M, Vs. Street Est of $4.8M
04:12 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (ECOR) ELECTROCORE Posts Q1 Revenue $5.4M, vs. Street Est of $4.8M
Press Release: ElectroCore Announces First Quarter 2024 Financial Results
electroCore Announces First Quarter 2024 Financial Results Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023 Company to host a conference call and webca
ElectroCore 1Q Sales $5.44M >ECOR
ElectroCore 1Q Sales $5.44M >ECOR
ElectroCore 1Q Loss/Shr 53c >ECOR
ElectroCore 1Q Loss/Shr 53c >ECOR
ElectroCore 1Q Loss $3.51M >ECOR
ElectroCore 1Q Loss $3.51M >ECOR
ElectroCore Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
ROCKAWAY, N.J., May 03, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the "Company"), (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that on May 1, 2024, Donald Melnikoff
ElectroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024
Truvaga Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market Expansion
ElectroCore Announces the Launch of Truvaga Plus for General Wellness
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile
Analysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)
Electrocore's Battle With Cyber Threats: Protecting Sensitive Data Amidst Rising Security Risks
HC Wainwright & Co. Reiterates Buy on ElectroCore, Maintains $15 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates electroCore with a Buy and maintains $15 price target.
Electrocore's Growth Trajectory: A Buy Rating With Promising Prospects
Earnings Call Summary | ElectroCore(ECOR.US) Q4 2023 Earnings Conference
The following is a summary of the ElectroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript:Financial Performance:ElectroCore reported a significant increase in annual revenue in 2023, growing by 87%
No Data